Vol 6, No 3 (2016)
- Year: 2016
- Published: 21.10.2016
- Articles: 10
- URL: https://ogsh.abvpress.ru/jour/issue/view/19
Full Issue
CASE REPORT
Hypercalcemic crisis. Clinical case
Abstract
Administration of calcium and vitamin D preparations always requires competent selection of doses, and combinations of drugs from a doctor as well as careful clinical and laboratory monitoring of the patient. Physician should always be aware of the danger of overdose, which can lead to very adverse consequences. An appearance of the first symptoms of overdose requires constant laboratory control and urgent measures to address this condition. One should also remember about other causes of hypercalcemia, which can help in the differential diagnosis. Clinical case presented by us is an example of how the lack of knowledge about the combined treatment of patients with postsurgical hypoparathyroidism can lead to some serious consequences such as hypercalcemic crisis.
64-66
67-70
DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORS
Basic principles of managing radiation and drug induced mucositis and dermatitis for oropharyngeal squamouscell carcinoma
Abstract
The work illustrates main issues of the radial treatment acceptability with the modification of patients with the squamous cell carcinoma of the oropharyngeal area. The spectrum of side effects is given and key issues of the accompanying therapy are concerned. Separately are given approaches to the treatment of patients with radial mucositis and dermatitis.
12-21
The use of Kuraderm drug in the treatment of basal cell carcinoma of the head and neck
Abstract
Basal cell carcinoma is one of the most common malignancies. Despite a wide range of treatment options and relatively good prognosis of the disease, there may be restrictions on the use of standard methods of treatment because of elderly patients, their physical condition and characteristics of the tumor localization. We provide clinical examples of successful treatment of basal cell carcinoma of the head and neck with Kuraderm BEC5. This is a drug with anti-tumor activity for topical use made on the basis of glycoalkaloids of plants of nightshade family.
22-26





